The Democratic Republic of Congo (DRC) has taken decisive steps to combat the monkeypox outbreak by approving two vaccines. This action comes amidst rising concerns over the spread of the virus, which causes symptoms ranging from mild to severe, including fever, rash, and swollen lymph nodes. By approving these vaccines, health authorities aim to mitigate the impact of the outbreak and protect vulnerable populations.